Could a "Shock and kill" strategy finally eradicate hidden HIV?
NCT ID NCT07577986
First seen May 12, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This early-stage trial tests a two-step approach to target hidden HIV. First, a drug called chidamide wakes up dormant HIV hiding in cells. Then, specially designed natural killer (NK) cells are infused to find and destroy those infected cells. The study enrolls 20 adults with well-controlled HIV on standard antiretroviral therapy to see if this combination is safe and can reduce the viral reservoir.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV (HUMAN IMMUNODEFICIENCY VIRUS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
the first affiliated hospital of Zhejiang university school of medicine, Hangzhou, Zhejiang 310000
Hangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.